Delivery Order SPE2DB20D3103-SPE2DB25FP2N7
- Not listed
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a ceiling value of $14,976.85 and a period of performance through May 20, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a ceiling value of $32,784.81 and is set to run through July 1, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $7,743.80. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, which are prescription diabetes medications. The contract has a performance period ending on July 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a firm fixed price ceiling value of $16,068.72 and a period of performance through June 17, 2025. This contract is not designated as a set-aside, indicating open competition. AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication, with a ceiling value of $40,910.13 and a period of performance through May 9, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The total ceiling value of the contract is $7,217.20, with a period of performance through July 17, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price of $9,348.53 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication, with an ultimate completion date of June 12, 2025. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,080.20, is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract is designated as firm fixed price and has an ultimate completion date of July 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,743.80, is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract is a firm-fixed price contract with a completion date of June 26, 2025. The contract is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a significant...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,483.01 contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) with a potential...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP2N7Delivery Order
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,346.08 and is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication, with a period of performance through June 24, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 6/23/25 |